Moderna Vaccine Produces Antibodies in Trial of Older People
Moderna Inc. headquarters stands in Cambridge, Massachusetts, U.S. (Photographer: Adam Glanzman/Bloomberg)

Moderna Vaccine Produces Antibodies in Trial of Older People

(Bloomberg) -- Moderna Inc. presented new safety data from an early trial that provides the first evidence that its Covid-19 vaccine stimulates the immune systems of older people.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.